FDA invests in clinical trial data

Share this article:

The FDA is putting up to $37.5 million toward improving clinical trials. Regulatory Focus reports that the regulator announced the money will go toward the Clinical Trials Transformation Initiative based at Duke University.

RF notes that the site is of note because the CTTI “includes nearly every government healthcare agency, pharmaceutical company and trade group as members, as well as several medical device manufacturers.”

RF says the goal of the multi-million-dollar effort is to improve data-driven decision-making.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.